Literature DB >> 8232958

Genetics of facioscapulohumeral muscular dystrophy: new mutations in sporadic cases.

R C Griggs1, R Tawil, D Storvick, J R Mendell, M R Altherr.   

Abstract

A gene for facioscapulohumeral muscular dystrophy (FSHD) has been linked to chromosome 4q35 in families with the disease. We have used recently characterized p13E-11/D4S809 probes that map near or within the FSHD gene to investigate eight sporadic cases of FSHD whose parents showed no signs of disease. Probe p13E-11/D4S809 detected novel DNA fragments in seven of the eight sporadic FSHD individuals and not in the parents, substantiating the clinical diagnosis. Two sisters with FSHD whose parents were clinically normal had a novel DNA fragment suggestive of germline mosaicism. Probe p13E-11/D4S809 is potentially helpful in genetic counseling. However, because this probe may also detect a locus unlinked to chromosome 4, because of possible genetic heterogeneity in FSHD, and because of the presence of recombinants in autosomal dominantly inherited families, closer markers or gene definition will be needed for accurate genetic counseling in other situations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232958     DOI: 10.1212/wnl.43.11.2369

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy.

Authors:  Silvère M van der Maarel; Rune R Frants
Journal:  Am J Hum Genet       Date:  2005-01-24       Impact factor: 11.025

2.  High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families.

Authors:  M Zatz; S K Marie; M R Passos-Bueno; M Vainzof; S Campiotto; A Cerqueira; C Wijmenga; G Padberg; R Frants
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

Review 3.  The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.

Authors:  Daphne Selvaggia Cabianca; Davide Gabellini
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

4.  De novo facioscapulohumeral muscular dystrophy defined by DNA probe p13E-11 (D4F104S1).

Authors:  P E Jardine; M C Koch; P W Lunt; J Maynard; K D Bathke; P S Harper; M Upadhyaya
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

5.  CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis.

Authors:  Autumn Rieken; Aaron D Bossler; Katherine D Mathews; Steven A Moore
Journal:  Neurology       Date:  2020-12-21       Impact factor: 9.910

6.  Elderly onset of weakness in facioscapulohumeral muscular dystrophy.

Authors:  Dominic B Fee
Journal:  Case Rep Neurol Med       Date:  2012-09-18

7.  Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.

Authors:  G Ricci; M Zatz; R Tupler
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

8.  Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.

Authors:  Giulia Ricci; Isabella Scionti; Francesco Sera; Monica Govi; Roberto D'Amico; Ilaria Frambolli; Fabiano Mele; Massimiliano Filosto; Liliana Vercelli; Lucia Ruggiero; Angela Berardinelli; Corrado Angelini; Giovanni Antonini; Elisabetta Bucci; Michelangelo Cao; Jessica Daolio; Antonio Di Muzio; Rita Di Leo; Giuliana Galluzzi; Elisabetta Iannaccone; Lorenzo Maggi; Valerio Maruotti; Maurizio Moggio; Tiziana Mongini; Lucia Morandi; Ana Nikolic; Ebe Pastorello; Enzo Ricci; Carmelo Rodolico; Lucio Santoro; Maura Servida; Gabriele Siciliano; Giuliano Tomelleri; Rossella Tupler
Journal:  Brain       Date:  2013-09-11       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.